Tag Archives: Daridorexant

Healing

EMA Panel Backs Daridorexant (Quviviq) for Insomnia

Posted on by admin
01
Mar

The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has recommended approval of daridorexant (Quviviq, Idorsia Pharmaceuticals) for the treatment of insomnia. Daridorexant is a dual orexin receptor antagonist that has been shown to increase sleep induction, improve sleep maintenance, and improve daytime functioning. The drug is indicated for the […]

Continue reading →
Healing

Daridorexant Secure, Efficient for Insomnia Dysfunction

Posted on by admin
07
Feb

FRIDAY, Feb. 4, 2022 (HealthDay News) — Daridorexant (50 mg) improves both nighttime symptoms and daytime functioning in people with insomnia disorder, according to a study published in the Feb. 1 issue of The Lancet Neurology. Emmanuel Mignot, M.D., from the Stanford Center for Sleep Research and Medicine in Palo Alto, California, and colleagues conducted […]

Continue reading →